Filter By Industry
Filter By Tag

Newsroom

Bioprognos SL Press releases

1 - 2 of 2 Press Releases

Apr 16, 2018
It is expected that the new test will save up to 90% of unnecessary breast biopsies that are usually done to confirm malignancy in suspicious findings in diagnostic imaging procedures (such as all classified as BI-RADS 3 and BI-RADS 4).

Dec 15, 2016
Bioprognos obtains the CE Declaration of Conformity for its algorithm to support the diagnosis of lung cancer after complying with the requirements of the European directive on medical devices and implementing a quality management system according to the.


Bioprognos SL RSS Feed